Structures by: Aakeröy C. B.
Total: 489
(1,3-Ph2acac)Co(II), 4-[(2-MeBenzIm)methyl]PhCONH2 (THF)
Co(C15H11O2)2(C16H15N3O)2(C4H8O)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.9670(6)Å b=11.2006(7)Å c=15.3238(9)Å
α=75.533(3)° β=80.377(4)° γ=79.221(4)°
Cu{[4-(5,6-dimethylbenzimidazol-1-yl)methyl]benzamide}2(F6-acac)2 (CH3CN)2
Cu(C17H17N3O)2(C5HO2F6)2(C2H3N)2
Inorganic Chemistry (2009) 48, 4052-4061
a=10.349(3)Å b=10.688(3)Å c=12.680(3)Å
α=98.217(6)° β=110.457(5)° γ=104.465(5)°
{3-[(pyrazol-1-yl)methyl]benzamide}2 (F6-acac)4 Cu(II)2
(C11H11N3O)2(C5H1F6O2)4Cu2
Inorganic Chemistry (2009) 48, 4052-4061
a=9.7354(11)Å b=11.1497(12)Å c=23.870(3)Å
α=90.00° β=96.985(2)° γ=90.00°
Bis{4-[(pyrazol-1-yl)methyl]benzamide} (Ph2-acac)2 Ni(II) bis{ethanol} (Ph2-acac)2 Ni(II)
(C11H11N3O)2(C15H11O2)2Ni(C2H6O)2(C15H11O2)2Ni
Inorganic Chemistry (2009) 48, 4052-4061
a=9.0170(6)Å b=12.3493(8)Å c=17.6357(12)Å
α=86.3190(10)° β=78.0890(10)° γ=72.2410(10)°
{3-[(pyrazol-1-yl)methyl]benzamide}2 (F6-acac)4 Cu(II)2
(C11H11N3O)2(C5H1F6O2)4Cu2
Inorganic Chemistry (2009) 48, 4052-4061
a=10.0325(10)Å b=15.1765(15)Å c=16.6440(16)Å
α=90.00° β=99.957(2)° γ=90.00°
527 4-[(2-phenylimidazol-1-yl)methyl]benzamide, mu-Cu2(F-PhCOO)4
(C17H15N3O)2(C7H4O2F)4Cu2(C2H3N)5
Inorganic Chemistry (2009) 48, 4052-4061
a=10.9536(9)Å b=11.2155(8)Å c=14.9765(12)Å
α=77.570(6)° β=78.159(4)° γ=74.526(5)°
BS-2-11e mu(o-FPhCOO)4 Cu2[4-imidazolylmethylbenzamide]2
(C11H11N3O)2Cu2(C7H4O2F)4
Inorganic Chemistry (2009) 48, 4052-4061
a=10.8218(9)Å b=19.4000(14)Å c=12.0541(8)Å
α=90.00° β=108.346(4)° γ=90.00°
BS-3-44-2A 4-[(pyrazol-1-yl)methyl]PhCONH2, mu4-(AcO)Cu CH3CN
(C11H11N3O)2Cu2(C2H3O2)4(C2H3N)2
Inorganic Chemistry (2009) 48, 4052-4061
a=7.5896(5)Å b=10.0990(7)Å c=13.3959(8)Å
α=68.531(4)° β=82.310(3)° γ=72.114(3)°
Mu(OAc)4 Cu2 {3-[(pyrazol-1-yl)methyl]benzamide}2
(C2H3O2)4Cu2(C11H11N3O1)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.0173(4)Å b=10.1615(5)Å c=11.4846(6)Å
α=110.1640(10)° β=109.1250(10)° γ=90.5040(10)°
Bis(F6-acac)bis[3-(2-amino-4-methylpyrimidin-6-yl)pyridine]copper(II) 1,2-dichloroethane
(C5H1O2F6)2(C10H10N4)2Cu1(C2H4Cl2)
Inorganic Chemistry (2005) 44, 4983-4991
a=8.2843(4)Å b=10.8750(5)Å c=11.7573(6)Å
α=113.0810(10)° β=94.4120(10)° γ=103.8330(10)°
(F6-acac)2[3-(2-amino-4-methoxypyrimidin-6-yl)pyridine]2Cu(II) (CHCl3)2
(C5HF6O2)2(C10H10N4O)2Cu(CHCl3)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4149(6)Å b=12.1682(7)Å c=18.2488(10)Å
α=105.6980(10)° β=105.8970(10)° γ=93.1160(10)°
1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, Cu(F6-acac)2
(C13H12N4O)Cu(C5HF6O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=9.6243(11)Å b=10.4481(12)Å c=13.8822(15)Å
α=85.905(2)° β=86.300(2)° γ=74.690(2)°
[1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne]2, Co(PhCOCCOPh)2
(C13H12N4O)2Co(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.5076(5)Å b=10.7568(6)Å c=11.9544(6)Å
α=68.9160(10)° β=82.6200(10)° γ=69.1900(10)°
1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, Ni(Ph2acac)2
Ni(C13H12N4O)2(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4666(7)Å b=10.6669(7)Å c=11.9828(8)Å
α=68.678(4)° β=82.626(4)° γ=69.230(3)°
4-[(2-chlorobenzimidazol-1-yl)methyl]benzamide
(C15H12ClN3O)(H2O)
Crystal Growth & Design (2005) 5, 3 1283
a=6.0212(10)Å b=12.4652(19)Å c=19.166(3)Å
α=90.00° β=90.00° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-benzimidazolyl)methyl]benzene
(C8H5BrN2O)2(C22H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=11.436(4)Å b=5.640(2)Å c=26.449(9)Å
α=90.00° β=99.252(5)° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=12.9436(5)Å b=5.1863(2)Å c=21.6419(9)Å
α=90.00° β=93.4500(10)° γ=90.00°
(4-bromo-PhC(CN)(=NOH))2, 1,4-di[(2-methyl-1-benzimidazolyl)methyl]benzene
(C8H5BrN2O)2(C24H22N4)
Crystal Growth & Design (2006) 6, 4 1033
a=7.4360(9)Å b=19.613(2)Å c=12.5107(15)Å
α=90.00° β=107.063(2)° γ=90.00°
(4-bromo-PhC(CN)(=NOH))2, 1,4-di[(2-methyl-1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C16H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=7.0034(8)Å b=10.6013(12)Å c=11.1605(12)Å
α=77.000(2)° β=75.995(2)° γ=84.920(2)°
(3-chloro-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5ClN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=5.9000(10)Å b=7.2231(12)Å c=17.088(3)Å
α=86.114(3)° β=89.633(4)° γ=73.472(3)°
1,4-[bis(2-methylbenzimidazol-1-yl)methyl]benzene, (4-bromobenzacetoxime)2
(C24H22N4)(C8H8NOBr)2
Crystal Growth & Design (2006) 6, 4 1033
a=10.9286(11)Å b=14.1612(15)Å c=11.3704(12)Å
α=90.00° β=92.619(2)° γ=90.00°
3-[(benzimidazol-1-yl)methyl]benzamide
C15H13N3O
Crystal Growth & Design (2005) 5, 3 1283
a=9.2133(11)Å b=11.6848(13)Å c=12.1071(15)Å
α=104.058(9)° β=98.623(8)° γ=94.900(7)°
3-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide
C15H12ClN3O
Crystal Growth & Design (2005) 5, 3 1283
a=8.8067(7)Å b=11.8803(12)Å c=14.0856(15)Å
α=74.800(4)° β=72.485(5)° γ=68.786(4)°
3-[(benzimidazol-1-yl)methyl]benzamide, 4-nitrobenzoic acid
(C15H13N3O)(C7H5NO4)
Crystal Growth & Design (2005) 5, 3 1283
a=7.5178(9)Å b=9.1850(11)Å c=15.0850(15)Å
α=105.516(6)° β=100.600(7)° γ=100.339(8)°
3-[(2-methylbenzimidazol-1-yl)methyl]PhCOOH,(4-NO2PhCOOH)2
(C16H15N3O)(C7H5NO4)2
Crystal Growth & Design (2005) 5, 3 1283
a=7.5292(5)Å b=11.0980(8)Å c=17.2512(11)Å
α=81.865(4)° β=77.854(3)° γ=74.581(4)°
[N-(2-pyridyl)acetamide]2, pentanedioic acid
(C7H8N2O)2(C5H8O4)
Crystal Growth & Design (2006) 6, 2 474
a=7.2671(11)Å b=34.592(5)Å c=8.6020(12)Å
α=90.00° β=114.553(2)° γ=90.00°
[N-(2-pyridyl)acetamide]2, heptanedioic acid
(C7H8N2O)2(C7H12O4)
Crystal Growth & Design (2006) 6, 2 474
a=14.3348(6)Å b=16.1008(7)Å c=18.8047(12)Å
α=90.00° β=90.0020(10)° γ=90.00°
[N-(2-pyridyl)acetamide]2, octanedioic acid
(C7H8N2O)2(C8H14O4)
Crystal Growth & Design (2006) 6, 2 474
a=13.566(2)Å b=9.2129(15)Å c=17.641(3)Å
α=90.00° β=101.162(2)° γ=90.00°
[N-(2-pyridyl) acetamide]2, fumaric acid
(C7H8N2O)2(C4H4O4)
Crystal Growth & Design (2006) 6, 2 474
a=4.8875(5)Å b=8.4817(8)Å c=11.4723(11)Å
α=110.375(2)° β=91.000(2)° γ=96.451(2)°
[N-(2-pyridyl)acetamide]2, succinic acid
(C7H8N2O)2(C4H6O4)
Crystal Growth & Design (2006) 6, 2 474
a=9.1172(8)Å b=9.2969(8)Å c=10.6430(9)Å
α=90.00° β=92.694(2)° γ=90.00°
[N-(2-pyridyl)acetamide]2, nonanedioic acid
(C7H8N2O)2(C9H16O4)
Crystal Growth & Design (2006) 6, 2 474
a=16.563(3)Å b=8.5279(12)Å c=18.464(3)Å
α=90.00° β=114.909(9)° γ=90.00°
[N-(2-pyridyl)acetamide]2, decanedioic acid
(C7H8N2O)2(C10H18O4)
Crystal Growth & Design (2006) 6, 2 474
a=5.3767(4)Å b=6.5416(4)Å c=17.0662(12)Å
α=92.8090(10)° β=90.2470(10)° γ=101.3140(10)°
N-(3-pyridyl)acetamide, 5-nitroisophthalic acid
(C7H8N2O)2(C8H5NO6)
Crystal Growth & Design (2006) 6, 2 474
a=19.5362(14)Å b=9.3631(7)Å c=12.7665(10)Å
α=90.00° β=113.382(4)° γ=90.00°
PC-4-10e (2-aminopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H5N3)2(C6I2F4)
Crystal Growth & Design (2011) 11, 12 5333
a=7.9013(6)Å b=5.6116(4)Å c=20.1258(16)Å
α=90.00° β=101.260(4)° γ=90.00°
4-11e 2-amino-5-bromopyrazine, 1,4-diiodotetrafluorobenzene
(C4H4N3Br)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6316(6)Å b=8.1219(9)Å c=21.226(2)Å
α=90.00° β=93.035(4)° γ=90.00°
4-12e (3-amino-2,6-dibromopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H3N3Br2)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6428(4)Å b=9.7705(7)Å c=10.4014(7)Å
α=100.821(3)° β=103.743(3)° γ=93.752(3)°
Isonicotinamide : form II
C6H6N2O
Crystal Growth & Design (2003) 3, 2 159
a=15.735(3)Å b=7.9976(18)Å c=9.885(3)Å
α=90.00° β=105.586(17)° γ=90.00°
2-hexenoic acid : isonicotinamide
C12H16N2O3
Crystal Growth & Design (2003) 3, 2 159
a=20.445(4)Å b=5.2309(9)Å c=23.008(4)Å
α=90.00° β=96.981(3)° γ=90.00°
Isonicotinamide : form I
C6H6N2O
Crystal Growth & Design (2003) 3, 2 159
a=10.1756(11)Å b=5.7319(6)Å c=10.0340(10)Å
α=90.00° β=98.042(7)° γ=90.00°
4-Chlorobenzamide : 3-Dimethylaminobenzoic acid
C16H17ClN2O3
Crystal Growth & Design (2003) 3, 2 159
a=7.1732(13)Å b=8.3689(17)Å c=12.997(3)Å
α=88.638(4)° β=80.875(4)° γ=77.463(4)°
Isonicotinamide : 4-nitrobenzoic acid
C13H11N3O5
Crystal Growth & Design (2003) 3, 2 159
a=20.512(4)Å b=5.1675(10)Å c=23.694(5)Å
α=90.00° β=90.66(3)° γ=90.00°
3,5-dinitrobenzoic acid : isonicotinamide : 4-toluic acid
C21H18N4O9
Crystal Growth & Design (2003) 3, 2 159
a=7.7628(11)Å b=8.7216(12)Å c=15.7426(19)Å
α=93.483(2)° β=98.981(3)° γ=93.913(2)°
2-amino-5-nitropyrimidine : 2-amino-3-nitropyridine
C9H9N7O4
Crystal Growth & Design (2003) 3, 2 159
a=11.786(3)Å b=5.1614(13)Å c=19.975(5)Å
α=90.00° β=95.275(5)° γ=90.00°
4-Chlorobenzamide : 3,5-Dinitrobenzoic acid
C14H10ClN3O7
Crystal Growth & Design (2003) 3, 2 159
a=7.2458(11)Å b=8.6260(13)Å c=13.2806(19)Å
α=92.566(3)° β=101.875(3)° γ=109.472(3)°
2(4-Chlorobenzamide) : Fumaric acid
C18H16Cl2N2O6
Crystal Growth & Design (2003) 3, 2 159
a=9.2674(8)Å b=10.1386(9)Å c=10.4805(10)Å
α=86.428(6)° β=72.174(6)° γ=89.506(7)°
CuCl4 + 2DMANH
C28H38Cl4CuN4
Crystal Growth & Design (2001) 1, 6 485
a=9.900(4)Å b=9.926(1)Å c=16.705(3)Å
α=83.825(12)° β=86.673(23)° γ=71.387(19)°
ZnCl4 + 2DMANH
C28H38Cl4N4Zn
Crystal Growth & Design (2001) 1, 6 485
a=15.237(3)Å b=11.774(2)Å c=17.443(4)Å
α=90.00° β=94.113(4)° γ=90.00°
Cu2Cl6 + 2PSPG
C14H19Cl3CuN2
Crystal Growth & Design (2001) 1, 6 485
a=14.816(3)Å b=12.460(2)Å c=18.734(3)Å
α=90.00° β=93.95(3)° γ=90.00°
SVP-4N-GA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)3-COOH
(C11H9N3O)(C5H8O4)
Crystal Growth & Design (2012) 12, 5 2579
a=5.1663(6)Å b=9.9211(10)Å c=15.8829(17)Å
α=75.339(3)° β=82.551(3)° γ=78.820(3)°
SVP-4N-PA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)5-COOH
(C11H9N3O)(C7H12O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5855(12)Å b=21.675(3)Å c=11.1031(16)Å
α=90.00° β=96.050(9)° γ=90.00°
SVP 4N-SeA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)6-COOH
(C11H9N3O)(C8H14O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.4438(7)Å b=10.1874(5)Å c=16.5671(9)Å
α=90.00° β=95.023(3)° γ=90.00°
SVP-4N-SeA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)8-COOH
(C11H9N3O)(C10H18O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.0319(11)Å b=9.9500(9)Å c=18.7354(18)Å
α=90.00° β=90.323(4)° γ=90.00°
SVP-4n-AzA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)7-COOH
(C11H9N3O)(C9H16O4)
Crystal Growth & Design (2012) 12, 5 2579
a=5.6707(3)Å b=10.8221(6)Å c=17.0848(10)Å
α=104.161(2)° β=94.599(2)° γ=104.840(2)°
SVP-3N-AA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)4-COOH
(C11H9N3O)(C6H10O4)
Crystal Growth & Design (2012) 12, 5 2579
a=8.9361(8)Å b=9.8031(9)Å c=9.8270(9)Å
α=83.130(2)° β=74.507(3)° γ=79.462(2)°
SVP-3N-SA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)2-COOH
(C11H9N3O)(C4H6O4)
Crystal Growth & Design (2012) 12, 5 2579
a=4.8289(5)Å b=11.1223(11)Å c=14.3787(14)Å
α=67.856(4)° β=89.550(4)° γ=87.878(4)°
SVP-3N-MA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)-COOH
(C11H9N3O)(C3H4O4)
Crystal Growth & Design (2012) 12, 5 2579
a=31.2168(18)Å b=4.7940(3)Å c=22.7743(13)Å
α=90.00° β=128.375(2)° γ=90.00°
(2) 3N/AZA BD (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)7-COOH
(C11H9N3O)(C9H16O4)
Crystal Growth & Design (2012) 12, 5 2579
a=13.5588(13)Å b=9.4660(10)Å c=15.8384(15)Å
α=90.00° β=105.946(4)° γ=90.00°
SVP-4N-AA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)4-COOH
(C11H9N3O)(C6H10O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.9508(11)Å b=19.8752(19)Å c=7.3996(8)Å
α=90.00° β=105.384(4)° γ=90.00°
SVP-4N-SUC (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)2-COOH
(C11H9N3O)(C4H6O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.2578(7)Å b=19.6623(11)Å c=19.8130(12)Å
α=93.236(3)° β=91.236(3)° γ=90.298(3)°
SVP-3N-PA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)5-COOH
(C11H9N3O)(C7H12O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5711(5)Å b=11.9820(8)Å c=20.1758(13)Å
α=82.560(4)° β=80.081(4)° γ=85.195(4)°
EH-4-97-4 4-Br-pyrazole, 3,5-(NO2)2-PhCOOH
(C3H3N2Br)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=7.6597(9)Å b=13.4779(16)Å c=13.7575(16)Å
α=117.048(4)° β=90.413(5)° γ=90.972(4)°
EH-1-25-05 4-CN-PhCOOH, 4-I-pyrazole
(C8H5NO2)(C3H3N2I)
Crystal Growth & Design (2012) 12, 11 5806
a=6.7767(5)Å b=8.0047(6)Å c=11.1806(10)Å
α=83.315(4)° β=77.745(4)° γ=85.862(4)°
EH-01-25-06 3,5-(NO2)2-PhCOOH, 4-I-pyrazole
(C7H4N2O6)(C3H3N2I)
Crystal Growth & Design (2012) 12, 11 5806
a=10.1937(6)Å b=11.2088(6)Å c=13.1357(7)Å
α=111.112(2)° β=108.116(2)° γ=92.381(2)°
EH-6-65-12 3,5-Me2-4-Cl-pyrazole, 3-MeO-4-HO-PhCOOH
(C5H7N2Cl)(C8H8O4)
Crystal Growth & Design (2012) 12, 11 5806
a=12.8138(7)Å b=7.2047(4)Å c=15.2522(9)Å
α=90.00° β=90.00° γ=90.00°
EH-6-65-11 3,5-Me2-4-Cl-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2Cl)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=6.4021(4)Å b=7.8731(5)Å c=28.0067(19)Å
α=90.00° β=90.195(3)° γ=90.00°
EH-4-45-3 3,5-Me2-4-Br-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2Br)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=6.4192(7)Å b=8.0239(8)Å c=28.206(3)Å
α=90.00° β=90.00° γ=90.00°
EH-6-65-6 (3,5-Me2-4-Cl-pyrazole)2, 2,4-(NO2)2-PhCOOH
(C5H7N2Cl)2(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=9.3369(18)Å b=10.489(2)Å c=11.923(2)Å
α=77.852(12)° β=75.218(11)° γ=68.606(12)°
EH-6-65-23 3,5-Me2-4-I-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2I)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=7.1993(5)Å b=7.8251(6)Å c=13.4055(10)Å
α=93.999(3)° β=90.564(3)° γ=96.990(3)°
EH-4-90-1 pyrazole, 3,5-Cl2-PhCOOH
(C3H4N2)(C7H4O2Cl2)2
Crystal Growth & Design (2012) 12, 11 5806
a=7.7111(12)Å b=9.6247(14)Å c=14.275(2)Å
α=73.355(8)° β=89.353(9)° γ=68.778(7)°
EH-3-94-1 3,5-Me2-pyrazole, 3,5-dinitrobenzoic acid hydrate
(C5H8N2)(C7H4N2O6)(H2O)
Crystal Growth & Design (2012) 12, 11 5806
a=8.6114(4)Å b=6.2504(3)Å c=27.4741(13)Å
α=90.00° β=94.822(3)° γ=90.00°
EH-3-93-7 pyrazole, [(NO2)2-PhCOOH]2
(C3H4N2)(C7H4N2O6)2
Crystal Growth & Design (2012) 12, 11 5806
a=7.1717(6)Å b=13.2773(12)Å c=20.7542(16)Å
α=90.00° β=92.463(4)° γ=90.00°
Mp-p1b-H29 [1,2,3]Triazolo[1,5-a]pyridine, 1,3,5-F3-2,4,6-I3-benzene
(C6H5N3)(C6F3I3)
CrystEngComm (2016) 18, 44 8631
a=9.3698(6)Å b=13.7351(9)Å c=12.2408(8)Å
α=90.00° β=90.6496(15)° γ=90.00°
Isonicotinamide, I2
(C6H6N2O)(I2)
Chemical Communications (Cambridge, United Kingdom) (2007) 41 4236-4238
a=7.6928(10)Å b=7.7411(10)Å c=8.1841(11)Å
α=80.734(2)° β=72.131(2)° γ=85.702(2)°
DW-10-8 (3-pyridyl)-CONH-(CH2)8-NHCO-(3-pyridyl), I-(CF2)4-I
(C20H26N4O2)(C4F8I2)
CrystEngComm (2014) 16, 44 10203
a=5.0194(3)Å b=5.0906(3)Å c=26.5502(14)Å
α=85.503(2)° β=85.901(2)° γ=88.2190(10)°
DW-6-18 (3-pyridyl)-COHN-(CH2)4-NHCO-(3-pyridyl), I-(CF2)8-I
(C16H18N4O2)(C8F16I2)
CrystEngComm (2014) 16, 44 10203
a=54.569(3)Å b=5.6337(3)Å c=9.7038(6)Å
α=90.00° β=92.370(2)° γ=90.00°
AR-1g-15 2-aminopyridine, HOOC-(CH2)8-COOH
(C5H6N2)2(C10H18O4)
CrystEngComm (2010) 12, 12 4231
a=8.2382(6)Å b=7.3603(5)Å c=17.7902(11)Å
α=90.00° β=102.979(3)° γ=90.00°
(N-5-bromo-2-pyridyl)-propionamide)2, octanedioic acid
(C8H9N2OBr)2(C8H14O4)
CrystEngComm (2010) 12, 12 4231
a=5.3172(2)Å b=8.6548(3)Å c=14.9927(6)Å
α=101.970(2)° β=93.037(2)° γ=100.816(2)°
AR-BI-C4 N-(5-bromo-2-pyridyl)propionamide, HOOC-(CH2)8-COOH
(C8H9N2OBr)2(C10H18O4)
CrystEngComm (2010) 12, 12 4231
a=5.1849(4)Å b=11.4665(8)Å c=12.4870(9)Å
α=71.293(2)° β=81.204(2)° γ=88.593(2)°
AR-1i-9 2-amino-3,5-dibromopyridine, 3,5-dinitrobenzoic acid
(C5H4Br2N2)(C7H4N2O6)
CrystEngComm (2010) 12, 12 4231
a=7.3849(5)Å b=31.340(2)Å c=13.3082(9)Å
α=90.00° β=90.344(3)° γ=90.00°
Adip+A44 4-pyridyl-CONH-(CH2)8-NHCO-4-pyridyl, HOOC-(CH2)8-COOH
(C20H26N4O2)(C6H10O4)
CrystEngComm (2014) 16, 26 5870
a=5.1403(3)Å b=5.2489(3)Å c=22.9829(15)Å
α=93.859(4)° β=95.267(4)° γ=91.289(4)°
KEPCY17 4-HO-PhC(CN)=NOH, [1-(4-pyridylmethyl)-5,6-dimethylbenzimidazole]2
(C8H6N2O2)(C15H15N3)2
CrystEngComm (2013) 15, 30 5946
a=6.1780(3)Å b=16.1233(9)Å c=16.2481(9)Å
α=85.088(2)° β=87.986(3)° γ=81.153(2)°
SF22 4-pyridyl-CONH-(CH2)6)-NHCO-(4-pyridyl), succinic acid CHUNKS
(C18H22N4O2)(C4H6O4)
Journal of the American Chemical Society (2009) 131, 17048-17049
a=5.1754(4)Å b=10.9294(8)Å c=10.9423(8)Å
α=118.826(4)° β=91.381(5)° γ=99.872(4)°
C5H7N3O3
C5H7N3O3
Journal of the American Chemical Society (1996) 118, 10134-10140
a=6.162(3)Å b=12.801(2)Å c=8.7770(10)Å
α=90.00° β=96.61° γ=90.00°
(1,3-Ph2acac)Ni(II), 4-[(2-MeBenzIm)methyl]PhCONH2 (THF)2
Ni(C15H11O2)2(C16H15N3O)2(C4H8O)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.9948(19)Å b=11.185(2)Å c=15.409(3)Å
α=75.737(9)° β=79.844(13)° γ=78.971(16)°
528 3-[(2-phenylimidazol-1-yl)methyl]benzamide, Cu2(2-FC6H4COO)4 (CH3CN)2
(C17H15N3O)2Cu2(C7H4O2F)4(C2H3N)4
Inorganic Chemistry (2009) 48, 4052-4061
a=10.9819(16)Å b=11.2072(15)Å c=14.926(2)Å
α=99.042(8)° β=91.419(6)° γ=116.183(7)°
Bis(1,3-Ph2propanedionato)-bis[3(2-amino-4-methoxypyrimidin-6-yl) pyridine]Co(II)
(C15H11O2)2(C10H10N4O)2Co
Inorganic Chemistry (2005) 44, 4983-4991
a=9.3368(7)Å b=10.3686(8)Å c=11.0609(8)Å
α=85.536(2)° β=79.677(2)° γ=83.026(2)°
4-[(2-methylbenzimidazol-1-yl)methyl]benzamide
C16H15N3O
Crystal Growth & Design (2005) 5, 3 1283
a=9.9852(13)Å b=15.912(2)Å c=8.3680(13)Å
α=90.00° β=93.480(9)° γ=90.00°
CuBr4 + 2DMANH
C28H38Br4CuN4
Crystal Growth & Design (2001) 1, 6 485
a=9.6535(9)Å b=9.7211(11)Å c=19.3952(17)Å
α=75.645(9)° β=77.522(6)° γ=65.741(9)°
SVP-3N-SeA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)8-COOH
(C11H9N3O)(C10H18O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5703(8)Å b=9.6882(10)Å c=13.9977(14)Å
α=85.455(4)° β=81.210(4)° γ=79.358(4)°